3 completed, 2 terminated. 3 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 3 | 2 | Terminated 2 |
Follow Icagen: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Assess Safety and Efficacy of Oral Senicapoc Administration on Exercise-induced Asthma senicapoc, Placebo - Exercise Induced Asthma | Phase 2 | Completed | Icagen | 69 | 2009-03-01 | 2011-07-14 |
| Safety and Efficacy Study of Oral Senicapoc on Allergen Challenge in Atopic Asthmatic Subjects senicapoc, Placebo - Atopic Asthma | Phase 2 | Completed | Icagen | 34 | 2008-10-01 | 2011-07-14 |
| A Study Evaluating the Long-Term Safety of ICA-17043 in Sickle Cell Disease Patients With or Without Hydroxyurea Therapy ICA-17043 - Sickle Cell Disease, Sickle Cell Anemia | Phase 3 | Terminated | Icagen | 51 | 2006-02-01 | 2007-09-11 |
| A Stratified Sickle Event Randomized Trial (ASSERT) ICA-17043 - Sickle Cell Disease | Phase 3 | Terminated | Icagen | 297 | 2005-02-01 | 2008-03-27 |
| A Study of the Efficacy and Safety of ICA-17043 (With or Without Hydroxyurea) in Patients With Sickle Cell Anemia. Low Dose ICA-17043, High dose ICA-17043, Placebo - Sickle Cell Disease, Sickle Cell Anemia | Phase 2 | Completed | Icagen | 90 | 2002-02-01 | 2011-07-18 |
Anemia, Sickle Cell (3) · Inflammation (2) · Anemia (1) · Asthma (1) · Asthma, Exercise-Induced (1) · Bronchial Spasm (1)
senicapoc (5)
United States (4) · United Kingdom (2) · Brazil (1) · France (1) · Jamaica (1) · Trinidad and Tobago (1)
Jonathan W Stocker, Ph.D. (1) · Jonathan W Stocker, PhD (1) · Jonathon Stocker, Ph.D. (1) · Kenneth I Ataga, MD (1) · Tak H Lee, FRCP (1)